• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Leading Pharmaceutical Experts Discuss, Define, Develop and Implement Crystallization Processes Through Increased Understanding & Control of Polymorphism

Posted on: Tuesday, 14 March 2006, 09:01 CST

NEW YORK, March 14 /PRNewswire/ -- Recognizing the need for pharmaceutical companies to achieve effective strategies for affecting the stability, solubility, and bioavailability of drug-metal complexes, role of single- crystal diffraction in identifying, characterizing and understanding polymorphism of pharmaceutical solids, and becoming aware of the mechanisms for the success and failure of formulation strategies used to improve dissolution and bioavailability, PharmaIQ, a division of the International Quality and Productivity Center (IQPC), announced their 6th Annual Polymorphism & Crystallization Conference, to take place May 22-24, 2006 at the Hilton San Diego/Del Mar, in Del Mar, CA.

The conference will feature case studies from a panel of pharmaceutical experts who have experienced the challenges Polymorphism & Crystallization -- and lived to tell about it.

Our speaker faculty includes experts from Merck & Co., Schering-Plough, Pfizer, Solvias AG, Sonus Pharmaceuticals, Inc., Transform Pharmaceuticals and many other leading global corporations. The conference will be Chaired by Dr. Harry Brittain of Center for Pharmaceutical Physics.

In addition to dynamic speaker presentations, the conference will include interactive Q&A and extensive networking opportunities. The event will commence on Monday, May 22nd with a full day of pre-conference workshops.

"We are excited about the impressive speaker faculty that will be involved, and the dialogue that will accompany this stimulating topic," said Raquel Luciano, Conference Director of the event.

For more information, please contact: Anne Marie Ricciardi Marketing Manager Pharma IQ, IQPC Phone: 212-885-2671 Email: Annemarie.Ricciardi@iqpc.com To register, please use registration code: US99PR1.

Receive up to $500 off of your registration fee if you register by 3/31/06!

About PharmaIQ, and IQPC:

PharmaIQ, a division of IQPC, is dedicated to providing practical, detailed information through educational conferences held at the national level. By providing accurate, objective and up-to-date developments and trends in pharmaceuticals, IQPC enables payers, providers and employers to remain competitive and profitable. The company prides itself on delivering dynamic, thought-provoking information through exhaustive research into the "best practices" of leading pharmaceutical corporations. We recognize the value of face-to-face forums, and strive to make each conference a valuable learning experience, allowing our attendees to receive a maximum return on investment. For more information please visit http://www.iqpc.com/pharmaIQ

http://www.iqpc.com/na-2067-06

PharmaIQ

CONTACT: Anne Marie Ricciardi, Marketing Manager, Pharma IQ, IQPC,+1-212-885-2671, Annemarie.Ricciardi@iqpc.com

Web site: http://www.iqpc.com/pharmaIQhttp://www.iqpc.com/na-2067-06

Source: PRNewswire

More News in this Category